Patient Positioning Articles & Analysis

MoreNova Turbo (MT) is a shockwaves device incorporating a compact and powerful energizer, in-line ultrasound localizer and easily interchangeable high-efficiency applicators. The novel applicators are designed to respectively deliver point, linear or planar shockwaves compatible with treating urinary stones, calcified leg arteries, prostate, Chronic Kidney Disease (CKD) and more. Target ...

By DirexGroup

TAE Life Sciences (TLS), a biological-targeting radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced a partnership with BEC GmbH (BEC) to incorporate a customized, robotic patient positioning system as part of its Alphabeam™ Neutron System for the high-precision radiation treatment of tumors. During BNCT, it is essential that the ...

By TAE Life Sciences (TLS)

Diagnostic Imaging spoke with Dr. Andre Kumar, a hospitalist at Stanford University Division of Hospital Medicine. Kumar is also the co-president of the Society of Hospital Medicine Bay Area Chapter and the director of the medicine consult and procedure service. Given his particular interest in the use of point-of-care ultrasound during the pandemic era, we spoke with him about how he is using ...

By Vave Health, Inc.

Spinologics Inc. and Importek have announced today the launch of Cervision™, an upper-extremity patient positioning device for cervical spine surgery, in Brazil. This launch marks the first international sales development of this product since its domestic introduction. “We are pleased to introduce Cervision™ in the Brazilian market”, says Dustin Arless, Director of ...

By Spinologics Inc

Kurin. Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture sets, announced the signing of a recent agreement with AllSpire Health GPO. The agreement is sole source and is for three years. “AllSpire Health GPO and Kurin are committed to patient safety by providing innovative solutions designed to address a common source of contaminated blood cultures and in doing ...

By Kurin, Inc.

The novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to infect naïve populations causing surges of critically ill patients who can survive their acute critical illness. Tracheostomy and gastrostomy are commonly paired procedures that bridge patients from their acute to subacute critical illness. Both are aerosolgenerating procedures that can ...

By CoapTech

PHILADELPHIA, March 01, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patients with autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for MuSK-CAART, or muscle-specific kinase (MuSK) chimeric ...

By Cabaletta Bio, Inc.

USA. Ergotrics is pleased to present the world’s first inflatable prone ventilation support to improve prone ventilation in the Intensive Care Unit (ICU). Scientific studies highlight the benefits of optimized PEEP and long recruitment for ARDS patients ventilated in alternating supine/prone position, but it is one of the most challenging and ergonomically demanding position changes for ...

By Ergotrics NV

People with disabilities (be they motor, sensory, or cognitive) now represent about 15% of the planet’s population (approximately 1 in 7 people). These are men and women who have the same need for health prevention screenings as people who do not have limitations. Despite current improvements (just think of the overcoming of architectural barriers in most buildings), it is quite evident ...

By Metaltronica S.p.A.

Exact Sciences today announced that its Oncotype DX Breast Recurrence Score test has been recognised as the only test that can be used for prediction of chemotherapy benefit in early-stage breast cancer patients with 1-3 positive axillary lymph nodes, including micro metastases, by the National Comprehensive Cancer Network (NCCN)ii in its updated guidelines for breast cancer. iii The Oncotype DX ...

By Exact Sciences UK, Ltd.

Quanta Dialysis Technologies Ltd (“Quanta” of the “Company”, a medical technology company committed to making kidney care more accessible with its SC+ haemodialysis system, announced today the results of the UK Dialysis Patient Experience Survey, showing the wide variance in care experienced by UK dialysis patients, as well as challenges faced in assessing self-care and ...

By QUANTA Dialysis Technologies

Caroline O. Pardo, Ph.D., General Manager for Haymarket Medical Education (HME), is pleased to announce that HME, based in Paramus, NJ, has been accredited as a provider of interprofessional continuing education (IPCE) by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nursing Credentialing Center ...

By Haymarket Events

Our Phase IIa clinical trial evaluating the safety, tolerability and possible efficacy of subcutaneous injections of ILB® in ALS is finalized and has been reported to the Swedish Medical Products Agency. The results indicate that, for the variants of ALS and the given dose investigated in the study, ILB® seems to have beneficial clinical effects without significant side effects. A ...

By TIKOMED AB

Antiprogestins act as Progesterone Receptor (PgR) antagonists. Novel and promising class of drugs to overcome endocrine resistance associated with ESR1 mutations. SMILE STUDY is a multi-institutional phase II clinical trial to determine the efficacy of an antiprogestin, Onapristone +fulvestrantas second line therapy for patients with HR+/HER2- metastatic breast cancer (MBC). Hypothesis: The ...

By Context Therapeutics Inc.

Telehealth and remote patient monitoring (RPM) have been found to effectively manage patient and population health. During a webinar with Fierce Healthcare last month, Glooko CEO Russ Johannesson joined Tufia Haddad, MD, Chair of Practice Innovation and Platform, The Mayo Clinic and Professor Carri W. Chan, PhD, Professor, Division of Decision, Risk and Operations and Faculty Director, ...

By Glooko, Inc.

Manassas, VA (March 8th, 2022) - Digital healthcare provider Notal Vision today announced that results of the first U.S.-based study with its investigational home-based optical coherence tomography (OCT) platform have been published in Ophthalmology Retina1. The Notal Home OCT pipeline technology is designed to provide patient-initiated retinal OCT scans to support the management of patients with ...

By Notal Vision, Inc.

ESR1 mutations are found in primary breast cancers prior to therapy initiation and are associated to worse relapse-free and overall survival. These results were reported today by a group of researchers from Lund University and Skåne University Hospital in a new studied published in JNCI Cancer Spectrum. The estrogen receptor alpha is one of the most important breast cancer biomarkers. It ...

By SAGA Diagnostics AB

Mevion Medical Systems today announced it has been selected by Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology to equip their new proton therapy center with a MEVION S250i Proton Therapy System® in Wuhan, China. The system at Tongji Hospital will feature Mevion’s industry leading HYPERSCAN® Pencil Beam Scanning (PBS) technology, ...

By Mevion Medical Systems

TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue allografts to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions, announced today that they had completed a new round of hiring for their two commercial subsidiaries Bio-Tissue and Amniox Medical. The recently hired sales representatives and associate sales ...

By Bio-Tissue, Inc.

Dr. Roisin Molloy, CEO, and co-founder of TriMedika; an innovative medical technology manufacturer, supplying the most accurate hospital-grade non-contact thermometers to hospitals worldwide, based in Belfast. Innovate UK launched Women in Innovation in 2016, after research revealed that just 1 in 7 applications for Innovate UK support came from women. Boosting the number of female entrepreneurs ...

By TriMedika